Private Wealth Management Group’s Denali Therapeutics DNLI Stock Holding History

Private Wealth Management Group’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.61K	Hold	296	–	–	﹤0.01%	666
2026 Q1	$5.68K	Hold	296	–	–	﹤0.01%	723
2025 Q4	$4.89K	Hold	296	–	–	﹤0.01%	782
2025 Q3	$4.3K	Hold	296	–	–	﹤0.01%	850
2025 Q2	$4.14K	Buy	+296	New	+$4.17K	﹤0.01%	834
2025 Q1	–	Sell	-260	Closed	-$5.3K	–	1513
2024 Q4	$5.3K	Hold	260	–	–	﹤0.01%	719
2024 Q3	$7.57K	Hold	260	–	–	﹤0.01%	561
2024 Q2	$6.04K	Buy	260 +236	+983%	+$4.53K	﹤0.01%	629
2024 Q1	$493	Sell	24 -25	-51%	-$470	﹤0.01%	1449
2023 Q4	$1.05K	Buy	+49	New	+$970	﹤0.01%	1247

Other funds holding DNLI

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Management Group's DNLI Position: Q2 2026 in Review

Private Wealth Management Group held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 296 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

Private Wealth Management Group first reported a position in DNLI in Q4 2023 and has held it in 10 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Private Wealth Management Group held 296 shares of Denali Therapeutics worth $7.61K as of Q2 2026.
Private Wealth Management Group left its Denali Therapeutics share count unchanged in Q2 2026.
Denali Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #666 holding.
Private Wealth Management Group first reported a position in Denali Therapeutics in Q4 2023 and has held it in 10 quarters since.
292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.